Industries > Pharma > Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029

Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029

Mammalian Cell Cultures, Microbial Fermentations, and Other Expression Systems; Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccines, and Others Therapeutic Areas

PUBLISHED: 07 November 2019
PAGES: 211
PRODUCT CODE: PHA0550

Clear
WOOCS 2.2.1

The biological drug API manufacturing market is estimated to grow at a CAGR of 9.5% in the first half of the forecast period. In 2018, Mammalian cell culture systems submarket represents the largest submarket within the biological drug API manufacturing industry.

How this 211-page report delivers:
• Biological Drug API Manufacturing Services market forecast to 2029

• Biological Drug API Manufacturing Services market forecast to 2029 by Expression Systems:
• Mammalian cell culture
• Microbial fermentation
• Other expression platforms

Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029

• Biological Drug API Manufacturing Services market forecast to 2029 by Therapeutic Area:
• Monoclonal antibody (mAb) therapies
• Vaccines
• Insulin therapies
• Interferon therapies
• Growth hormones
• Other Therapeutic Areas

• Biological Drug API Manufacturing Services market forecast to 2029 by Regional and National Market:
• North America: US, Canada
• Europe: Germany, France, the UK, Switzerland, Spain, Italy, Rest of Europe
• BRIC: Brazil, Russia, China, India
• Japan
• South Korea
• Singapore
• RoW

• Profiles leading companies that offer biotech API manufacturing services to the pharmaceutical industry. Leading CMOs profiled in this report are:
• Abbvie
• Boehringer Ingelheim BioXcellence
• Catalent
• Celltrion
• Cytovance Biologics
• Fujifilm Diosynth Biotechnologies
• GSK
• Lonza
• Patheon N.V.
• Rentschler Biopharma
• Samsung BioLogics
• Sandoz
• Teva

• Provides qualitative analysis: SWOT and STEP Analysis of the biological drug API manufacturing market.

• Key questions answered by this report:
• How is the biological drug API manufacturing services market evolving?
• What is driving and restraining the biological drug API manufacturing services market?
• What are the market shares of each main segment of the overall biological drug API manufacturing services market in 2018?
• How will each main biological drug API manufacturing services submarket grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for biological drug API manufacturing services submarkets develop from 2019 to 2029?
• What will be the main drivers for the overall market from 2019 to 2029?
• How will political and regulatory forces influence the regional markets and submarkets?
• Will leading national biological drug API manufacturing services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2029 and which countries will lead the market in 2029?
• Who are the leading companies and what are their prospects?
• What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?
• How will the industry evolve during the period 2019 to 2029, and which trends will be important?

Visiongain’s study is intended for anyone requiring commercial analyses for the biological drug API manufacturing market. You find data, trends and predictions.

Buy our report today Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029: Mammalian Cell Cultures, Microbial Fermentations, and Other Expression Systems; Human Growth Hormones, Insulin, Interferons, Monoclonal Antibodies, Vaccines, and Others Therapeutic Areas.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com

Download sample pages

Complete the form below to download your free sample pages for Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029


Download sample pages

Complete the form below to download your free sample pages for Biological Drug API Manufacturing Services World Industry and Market Forecast to 2029


Latest Pharma news

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

READ

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

READ

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

READ

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

READ

Categories

Category